Literature DB >> 1889128

Primary localized cutaneous amyloidosis and familial medullary thyroid carcinoma.

J P Ferrer1, I Halperin, J I Conget, M Alsina, M J Martinez-Osaba, J Palou, J A Bombi, E Vilardell.   

Abstract

We have studied a family with an autosomal dominant inheritance of primary localized cutaneous amyloidosis (PLCA) and familial medullary thyroid carcinoma (MTC). Ten family members were screened for multiple endocrine neoplasia (MEN) 2; five were found to have MTC and two had C-cell hyperplasia. None had evidence of phaeochromocytoma or parathyroid abnormalities. Five of these seven patients presented characteristic interscapular hyperpigmented lesions, showing dermal amyloid deposits in two of the four patients in which a biopsy was performed. The data are analysed in the light of two recent reports of MEN 2A associated with identical lesions. We conclude that PLCA should be sought in MTC patients, even if no other endocrinopathies are present. This may be informative of the familial character of MTC in index cases and also of the tumour gene status in family members who are being screened.

Entities:  

Mesh:

Year:  1991        PMID: 1889128     DOI: 10.1111/j.1365-2265.1991.tb00322.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

Review 1.  MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics.

Authors:  Jessica Oliboni Scapineli; Lucieli Ceolin; Márcia Khaled Puñales; José Miguel Dora; Ana Luiza Maia
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

2.  Multiple endocrine neoplasia type 2A/localized cutaneous lichen amyloidosis associated with malignant pheochromocytoma and ganglioneuroma.

Authors:  S Gullu; A Gursoy; M F Erdogan; S Dizbaysak; G Erdogan; N Kamel
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

3.  Multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis: description of a new family.

Authors:  F Pacini; L Fugazzola; G Bevilacqua; P Viacava; V Nardini; E Martino
Journal:  J Endocrinol Invest       Date:  1993-04       Impact factor: 4.256

4.  Identification of the Cys634-->Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis.

Authors:  I Ceccherini; C Romei; V Barone; F Pacini; E Martino; A Loviselli; A Pinchera; G Romeo
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

5.  RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D.

Authors:  Xiao-Ping Qi; Jian-Qiang Zhao; Zhen-Guang Chen; Jin-Lin Cao; Juan Du; Nai-Fang Liu; Feng Li; Mao Sheng; Er Fu; Jian Guo; Hong Jia; Yi-Ming Zhang; Ju-Ming Ma
Journal:  Oncotarget       Date:  2015-10-20

Review 6.  5P Strategies for Management of Multiple Endocrine Neoplasia Type 2: A Paradigm of Precision Medicine.

Authors:  Shu-Yuan Li; Yi-Qiang Ding; You-Liang Si; Mu-Jin Ye; Chen-Ming Xu; Xiao-Ping Qi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-18       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.